Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study

Published:2019-01-04 Issue:1 Volume:14 Page:e0210593
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bekker Pirow,Dairaghi Daniel,Seitz Lisa,Leleti Manmohan,Wang Yu,Ertl Linda,Baumgart Trageen,Shugarts Sarah,Lohr Lisa,Dang Ton,Miao Shichang,Zeng Yibin,Fan Pingchen,Zhang Penglie,Johnson Daniel,Powers Jay,Jaen Juan,Charo Israel,Schall Thomas J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference1 articles.

1. Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study;P Bekker;PLoS ONE,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants;Clinical Pharmacology in Drug Development;2024-02-29

2. Main tract stenosis complicated by granulomatous with polyangiitis: A case report;Experimental and Therapeutic Medicine;2020-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP